|
BMC Pediatrics 2012
Assessing children’s competence to consent in research by a standardized tool: a validity studyKeywords: Competence, Consent, Assessment, Tool, Drug trial, Informed consent, Decision making, Research, Child, Adolescent Abstract: In this study we modified the MacCAT-CR, the best evaluated competence assessment tool for adults, for use in children and adolescents. We will administer the tool prospectively to a cohort of pediatric patients from 6 to18 years during the selection stages of ongoing clinical trials. The outcomes of the MacCAT-CR interviews will be compared to a reference standard, established by the judgments of clinical investigators, and an expert panel consisting of child psychiatrists, child psychologists and medical ethicists. The reliability, criterion-related validity and reproducibility of the tool will be determined. As MacCAT-CR is a multi-item scale consisting of 13 items, power was justified at 130–190 subjects, providing a minimum of 10–15 observations per item. MacCAT-CR outcomes will be correlated with age, life experience, IQ, ethnicity, socio-economic status and competence judgment of the parent(s). It is anticipated that 160 participants will be recruited over 2 years to complete enrollment.A validity study on an assessment tool of competence to consent is strongly needed in research practice, particularly in the child and adolescent population. In this study we will establish a reference standard of children’s competence to consent, combined with validation of an assessment instrument. Results can facilitate responsible involvement of children in clinical trials by further development of guidelines, health-care policies and legal policies.Currently over 50% of drugs prescribed to children have not been properly evaluated for safety and efficacy in their age group. One key reason why children have been excluded from clinical trials is that they are not considered capable of understanding research information. This means that they are not considered able to exercise meaningful autonomy over the decision on trial participation. By Dutch law, competence to consent in children is presumed to be present at the age of 12 and above. In pediatric clinical practice, thoug
|